- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Abnormal Uterine Bleeding, Unspecified in Hong Kong
Total 10 results
-
Chinese University of Hong KongCompletedEndometrial Cancer | Postmenopausal BleedingHong Kong
-
Chinese University of Hong KongRecruitingPostmenopausal BleedingHong Kong
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditionsUnited States, Hong Kong, Canada
-
Glenveigh MedicalTerminatedPostpartum Uterine BleedingUnited States
-
Myovant Sciences GmbHCompletedUterine Fibroid | Heavy Menstrual BleedingUnited States, Belgium, Czechia, South Africa, Chile, Brazil, Hungary, Poland
-
AbbVieCompletedUterine Fibroids | Heavy Menstrual BleedingUnited States, Canada, Puerto Rico
-
Myovant Sciences GmbHCompletedUterine Fibroid | Heavy Menstrual BleedingUnited States, Italy, Belgium, Czechia, Hungary, Poland, South Africa, Chile, Brazil
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IIA Cervical Cancer AJCC v7 | Stage IIB Cervical Cancer AJCC v6 and v7 | Stage III Cervical Cancer AJCC v6 and v7 | Stage IB Cervical Cancer AJCC v6 and v7United States, Canada
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IIA Cervical Cancer AJCC v7 | Stage IB Cervical Cancer AJCC v6 and v7 | Stage I Cervical Cancer AJCC v6 and v7 | Stage IA Cervical Cancer AJCC v6 and v7United States, Korea, Republic of, Japan
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditionsUnited States